ALMDT Stock Overview
Develops and markets software products and platforms for medical image analysis in France, the United States, Canada, the United Kingdom, China, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 2/6 |
| Past Performance | 0/6 |
| Financial Health | 1/6 |
| Dividends | 0/6 |
Median Technologies SA Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €3.48 |
| 52 Week High | €6.77 |
| 52 Week Low | €2.33 |
| Beta | 1.06 |
| 1 Month Change | 4.19% |
| 3 Month Change | -9.14% |
| 1 Year Change | -24.10% |
| 3 Year Change | -75.93% |
| 5 Year Change | 152.17% |
| Change since IPO | -65.48% |
Recent News & Updates
Recent updates
Investors Give Median Technologies SA (EPA:ALMDT) Shares A 28% Hiding
Mar 14
Median Technologies SA (EPA:ALMDT) Looks Just Right With A 26% Price Jump
Jan 03Newsflash: Median Technologies SA (EPA:ALMDT) Analysts Have Been Trimming Their Revenue Forecasts
Jul 14Median Technologies SA (EPA:ALMDT) Might Not Be As Mispriced As It Looks After Plunging 46%
May 05Is Median Technologies (EPA:ALMDT) Using Too Much Debt?
May 07Announcing: Median Technologies (EPA:ALMDT) Stock Increased An Energizing 254% In The Last Year
Dec 28Shareholder Returns
| ALMDT | FR Healthcare Services | FR Market | |
|---|---|---|---|
| 7D | 8.4% | -0.3% | -1.8% |
| 1Y | -24.1% | 5.0% | 7.4% |
Return vs Industry: ALMDT underperformed the French Healthcare Services industry which returned 5% over the past year.
Return vs Market: ALMDT underperformed the French Market which returned 7.4% over the past year.
Price Volatility
| ALMDT volatility | |
|---|---|
| ALMDT Average Weekly Movement | 15.7% |
| Healthcare Services Industry Average Movement | 5.8% |
| Market Average Movement | 4.5% |
| 10% most volatile stocks in FR Market | 9.6% |
| 10% least volatile stocks in FR Market | 2.3% |
Stable Share Price: ALMDT's share price has been volatile over the past 3 months.
Volatility Over Time: ALMDT's weekly volatility has increased from 10% to 16% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2002 | 256 | Fredrik Brag | www.mediantechnologies.com |
Median Technologies SA develops and markets software products and platforms for medical image analysis in France, the United States, Canada, the United Kingdom, China, and internationally. The company offers iBiops, an end-to-end AI-powered technology software as a medical device for early diagnosis of cancers and fibrotic diseases; iSee for image analysis services in clinical trials; and iCRO, which engages in the sale of imaging services for clinical trials in oncology using software. The company was founded in 2002 and is based in Valbonne, France.
Median Technologies SA Fundamentals Summary
| ALMDT fundamental statistics | |
|---|---|
| Market cap | €64.01m |
| Earnings (TTM) | -€22.98m |
| Revenue (TTM) | €22.78m |
2.8x
P/S Ratio-2.8x
P/E RatioIs ALMDT overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ALMDT income statement (TTM) | |
|---|---|
| Revenue | €22.78m |
| Cost of Revenue | €24.78m |
| Gross Profit | -€2.00m |
| Other Expenses | €20.99m |
| Earnings | -€22.98m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -1.25 |
| Gross Margin | -8.77% |
| Net Profit Margin | -100.89% |
| Debt/Equity Ratio | -210.3% |
How did ALMDT perform over the long term?
See historical performance and comparison